(Q78306911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

title

Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

main subject

acute myeloid leukemia

1 reference

childhood acute myeloid leukemia

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

S C Raimondi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

A R Halbert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

X Tong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

D K Srivastava

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

B I Razzouk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

C-H Pui

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

J R Downing

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

R C Ribeiro

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

F G Behm

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

2072-2077

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12357359%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402633

13 December 2019

exact match

0 references

cites work

Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Good outcome of children with acute myeloid leukemia and t(8;21)(q22;q22), even when associated with granulocytic sarcoma: a report from a single institution in Argentina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Extramedullary myeloid tumors in children: the limited value of local treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Cytogenetically cryptic AML1-ETO and CBFbeta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

A direct bone marrow chromosome technique for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021

Clinical importance of cytogenetics in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402633

7 January 2021